DENTSPLY SIRONA Inc. (XRAY): Stock Performance Post-Cramer's Remarks
Money

DENTSPLY SIRONA Inc. (XRAY): Stock Performance Post-Cramer's Remarks

authorBy Scott Pape
DateJul 07, 2026
Read Time2 min

DENTSPLY SIRONA Inc. (XRAY), a prominent dental product manufacturer, has recently drawn attention due to its stock performance following remarks by financial commentator Jim Cramer. Over the past year, the company's shares have seen a significant decline of 26.9%, although they have shown a 3.4% increase year-to-date.

Following Cramer's initial discussion of the firm on January 6th, where he highlighted its potential value despite a previous drop from being a high-growth company, DENTSPLY SIRONA reported its fourth-quarter earnings on February 26th. The report indicated revenues of $961 million and earnings per share of $0.27, surpassing analyst expectations for revenue but falling short on earnings. This announcement led to a notable 15.5% surge in XRAY's share price on February 27th. However, the momentum was not sustained, as the stock closed 2% lower on May 6th after the company's first-quarter earnings showed a 39% year-over-year decline in earnings per share.

The trajectory of DENTSPLY SIRONA's stock illustrates the dynamic nature of market reactions to both expert commentary and financial results. While the company's recent earnings report presented mixed results, the initial positive response to Cramer's endorsement suggests that investor sentiment plays a crucial role in short-term market movements. Investors are always seeking opportunities for growth, and while XRAY shows volatility, its long-term potential, especially with a renewed focus on value by analysts, remains a key point of interest in the investment community. This highlights the importance of thorough research and a balanced perspective when evaluating investment opportunities, moving beyond immediate market fluctuations to consider underlying business fundamentals and expert insights.

More Articles
Money
Meta's Stock Performance: A Contrarian View Amidst Market Fluctuations
Despite market dips, Jim Cramer has consistently supported Meta Platforms, Inc. (META) since late 2025, advocating for its aggressive capital expenditure in AI. He argued that the investments are crucial for Meta to maintain its competitive edge against rivals like OpenAI. Cramer's stance highlights the ongoing debate about Meta's strategic spending and its impact on stock valuation.
By Scott PapeJul 07, 2026
Money
CME Group: A Strategic Investment for Volatility Hedging and Growth Potential
CME Group Inc. (NASDAQ:CME), a leading derivatives marketplace, has garnered attention from financial analysts and investors like billionaire Jeffrey Talpins. Despite recent stock fluctuations, experts see an attractive entry point due to increasing interest in retail trading and prediction markets. The company's diverse offerings and capacity to act as a volatility hedge in uncertain economic climates position it as a noteworthy investment, with potential for revenue growth driven by global tensions and interest rate dynamics.
By Chika UwazieJul 07, 2026
Money
Analyzing Pinterest's Stock Performance: Is It a Worthwhile Investment?
Pinterest's stock has seen significant fluctuations, with a 38% decline over the past year and a 16.9% drop year-to-date. Despite missing some analyst estimates in Q4 2026, the company's Q1 results showed improvement, exceeding revenue and EPS forecasts. However, an investor's letter from TimesSquare Capital U.S. Mid Cap Growth Strategy reveals a decision to exit their position due to advertising pullbacks and cautious guidance, prompting a reevaluation of PINS' investment potential.
By Vicki RobinJul 07, 2026
Money
Palantir Stock Performance and Analyst Sentiment
Palantir Technologies Inc. (PLTR) has experienced significant stock fluctuations despite positive commentary from financial analysts like Jim Cramer. While Cramer lauded its growth and efficiency contributions, the company's shares have seen considerable declines, facing challenges from short sellers and market reactions to earnings reports. However, periods of market enthusiasm for the software sector have also provided temporary boosts. The article also suggests that other AI stocks may offer more favorable risk-reward profiles.
By JL CollinsJul 07, 2026
Money
QXO, Inc. Stock Decline Post Jim Cramer's 'Buy' Recommendation
Despite Jim Cramer's past endorsement, QXO, Inc. (NYSE:QXO) has seen a significant downturn in its stock performance. Shares have fallen 25% over the last year and 17.8% year-to-date, with a notable drop following the TopBuild acquisition where shareholders opted for cash over stock. Analysts from Citi and Stephens have revised their price targets downwards, yet maintained 'Buy' and 'Overweight' ratings, citing the company's effective margin control strategies. Cramer himself expressed confidence due to Brad Jacobs' leadership, despite a 10% short position.
By Vicki RobinJul 07, 2026